NCT04941833

Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo

The Use of Oral Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo : A Randomized Controlled Trial Evaluation of the Effect on Cyst Diameter and Associated Pain

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Department of Medical Services Ministry of Public Health of Thailand · Other Government
• Sex: Female
• Age: 15 Years – 49 Years
• Healthy volunteers: Accepted

Summary

Use of the oral desogestrel compared with placebo for preoperative treatment of endometrioma in the patient who underwent to surgery in next 3 months The result will be evaluated on cyst diameter, the associated pain and side effect of the oral desogestrel.

Detailed description

Use of the oral desogestrel compared with placebo for preoperative treatment of endometrioma in the patient who underwent to surgery in next 3 months in Rajvithi hospital Patient will randomized in 2 group : Desogestrel and placebo After 1 months and 3 months the patient have to come to hospital to evaluate the result of study The result will be evaluated on cyst diameter, the associated pain and side effect of the oral desogestrel.

Conditions

• Endometrioma

Interventions

Type	Name	Description
DRUG	Desogestrel Oral Tablet	Cerazette is the brand name of the desogestrel which contain of 0.075 mg of desogestrel

Timeline

• Start date: 2021-06-01
• Primary completion: 2022-07-31
• Completion: 2022-09-30
• First posted: 2021-06-28
• Last updated: 2022-10-31

Locations

1 site across 1 country: Thailand